China Resources Boya Bio-pharmaceutical Group Co.,Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 21
Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedMar 24, 2025
DataAggregated Company Financials
Companies72
- 7D-1.9%
- 3M-0.2%
- 1Y-12.1%
- YTD6.0%
Over the last 7 days, the Biotech industry has dropped 1.9%, driven by Imeik Technology DevelopmentLtd declining 8.0%. The industry has fallen 12% in the last year. Earnings are forecast to grow by 42% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 25 Mar 2025 | CN¥850.7b | CN¥136.2b | CN¥11.7b | 32.1x | 72.5x | 6.2x |
| Thu, 20 Feb 2025 | CN¥836.3b | CN¥136.0b | CN¥10.8b | 34.3x | 77.7x | 6.1x |
| Sat, 18 Jan 2025 | CN¥800.1b | CN¥136.0b | CN¥10.8b | 32.7x | 74.4x | 5.9x |
| Mon, 16 Dec 2024 | CN¥888.3b | CN¥136.0b | CN¥10.8b | 33.9x | 82.6x | 6.5x |
| Wed, 13 Nov 2024 | CN¥980.2b | CN¥141.7b | CN¥11.2b | 39x | 87.5x | 6.9x |
| Fri, 11 Oct 2024 | CN¥947.5b | CN¥154.1b | CN¥14.5b | 37.6x | 65.6x | 6.1x |
| Sun, 08 Sep 2024 | CN¥758.2b | CN¥154.2b | CN¥14.5b | 30.5x | 52.2x | 4.9x |
| Tue, 06 Aug 2024 | CN¥819.4b | CN¥161.2b | CN¥17.3b | 31.2x | 47.3x | 5.1x |
| Thu, 04 Jul 2024 | CN¥816.5b | CN¥161.1b | CN¥17.3b | 30.1x | 47.2x | 5.1x |
| Sat, 01 Jun 2024 | CN¥906.1b | CN¥161.1b | CN¥17.3b | 35.3x | 52.4x | 5.6x |
| Mon, 29 Apr 2024 | CN¥927.1b | CN¥161.8b | CN¥18.3b | 35x | 50.8x | 5.7x |
| Wed, 27 Mar 2024 | CN¥980.5b | CN¥164.4b | CN¥21.9b | 36.7x | 44.9x | 6x |
| Fri, 23 Feb 2024 | CN¥979.8b | CN¥167.9b | CN¥21.4b | 33.8x | 45.7x | 5.8x |
| Sun, 21 Jan 2024 | CN¥1.0t | CN¥167.9b | CN¥21.4b | 35.7x | 46.9x | 6x |
| Tue, 19 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.7x | 50.9x | 6.5x |
| Thu, 16 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 41.4x | 51.7x | 6.6x |
| Sat, 14 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 44.3x | 43.1x | 6.4x |
| Mon, 11 Sep 2023 | CN¥998.8b | CN¥170.7b | CN¥25.3b | 37.5x | 39.4x | 5.8x |
| Wed, 09 Aug 2023 | CN¥1.1t | CN¥174.4b | CN¥28.4b | 38.7x | 37x | 6x |
| Fri, 07 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 38.7x | 36.2x | 6x |
| Sun, 04 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 42x | 38.3x | 6.3x |
| Tue, 02 May 2023 | CN¥1.2t | CN¥180.7b | CN¥31.8b | 43.4x | 38.6x | 6.8x |
| Thu, 30 Mar 2023 | CN¥1.2t | CN¥186.5b | CN¥37.1b | 39.4x | 33.1x | 6.6x |
| Sat, 25 Feb 2023 | CN¥1.3t | CN¥179.4b | CN¥37.9b | 44.2x | 33.9x | 7.2x |
| Mon, 23 Jan 2023 | CN¥1.3t | CN¥179.6b | CN¥38.2b | 42.6x | 34.9x | 7.4x |
| Wed, 21 Dec 2022 | CN¥1.2t | CN¥175.6b | CN¥37.9b | 37.5x | 31.5x | 6.8x |
| Fri, 18 Nov 2022 | CN¥1.3t | CN¥175.5b | CN¥37.9b | 41.5x | 33.9x | 7.3x |
| Sun, 16 Oct 2022 | CN¥1.2t | CN¥174.5b | CN¥40.3b | 33.7x | 29.8x | 6.9x |
| Tue, 13 Sep 2022 | CN¥1.2t | CN¥174.0b | CN¥40.1b | 34x | 30.6x | 7.1x |
| Thu, 11 Aug 2022 | CN¥1.2t | CN¥171.2b | CN¥43.3b | 35.4x | 28.9x | 7.3x |
| Sat, 09 Jul 2022 | CN¥1.3t | CN¥168.1b | CN¥42.4b | 38.7x | 31.7x | 8x |
| Mon, 06 Jun 2022 | CN¥1.2t | CN¥168.1b | CN¥42.4b | 36.9x | 28x | 7.1x |
| Wed, 04 May 2022 | CN¥1.2t | CN¥163.1b | CN¥35.9b | 36.8x | 33.5x | 7.4x |
| Fri, 01 Apr 2022 | CN¥1.5t | CN¥155.0b | CN¥41.5b | 44.4x | 35.3x | 9.4x |
Price to Earnings Ratio
35.3x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 72.5x which is higher than its 3-year average PE of 45.3x.
- The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 34% per year over the last three years,
- Revenues have also declined 4.2% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -2.08% | |
| Healthcare | -1.71% | |
| Biotech | -1.94% | |
| Biotech | -1.94% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688192 Dizal (Jiangsu) Pharmaceutical | CN¥46.69 | 3.0% +CN¥559.6m | 9.7% | PS54.1x | |
| 688278 Xiamen Amoytop Biotech | CN¥80.33 | 1.7% +CN¥553.2m | 20.7% | PE39.5x | |
| 600645 Vcanbio Cell & Gene Engineering | CN¥23.19 | 5.5% +CN¥551.6m | 40.5% | PE98.4x | |
| 688336 Sunshine Guojian Pharmaceutical (Shanghai) | CN¥27.91 | 2.4% +CN¥400.9m | 17.7% | PE23.5x | |
| 688136 Kexing Biopharm | CN¥22.77 | 8.6% +CN¥357.9m | 38.6% | PE142.8x |
